224 related articles for article (PubMed ID: 22314363)
1. EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.
Li G; Ji XD; Gao H; Zhao JS; Xu JF; Sun ZJ; Deng YZ; Shi S; Feng YX; Zhu YQ; Wang T; Li JJ; Xie D
Nat Commun; 2012 Feb; 3():667. PubMed ID: 22314363
[TBL] [Abstract][Full Text] [Related]
2. EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer.
Li JJ; Sun ZJ; Yuan YM; Yin FF; Bian YG; Long LY; Zhang XL; Xie D
J Biol Chem; 2017 Jan; 292(3):1112-1121. PubMed ID: 27986811
[TBL] [Abstract][Full Text] [Related]
3. RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway.
Shi S; Deng YZ; Zhao JS; Ji XD; Shi J; Feng YX; Li G; Li JJ; Zhu D; Koeffler HP; Zhao Y; Xie D
J Biol Chem; 2012 Mar; 287(11):7845-58. PubMed ID: 22262830
[TBL] [Abstract][Full Text] [Related]
4. EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration.
Ji XD; Li G; Feng YX; Zhao JS; Li JJ; Sun ZJ; Shi S; Deng YZ; Xu JF; Zhu YQ; Koeffler HP; Tong XJ; Xie D
Cancer Res; 2011 Feb; 71(3):1156-66. PubMed ID: 21266352
[TBL] [Abstract][Full Text] [Related]
5. EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway.
Xiao Z; Huang S; Qiu W; Pang M; Zeng X; Xu X; Yang Y; Yang B; Chu L
Brain Res; 2024 May; 1830():148796. PubMed ID: 38341169
[TBL] [Abstract][Full Text] [Related]
6. RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex.
Fei L; Ma Y; Zhang M; Liu X; Luo Y; Wang C; Zhang H; Zhang W; Han Y
Oncotarget; 2017 Jun; 8(25):40501-40513. PubMed ID: 28465488
[TBL] [Abstract][Full Text] [Related]
7. PHB2 promotes tumorigenesis
Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
[No Abstract] [Full Text] [Related]
8. Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Bhatia S; Griego A; Lennon S; Oweida A; Sharma J; Rohmer C; Uyanga N; Bukkapatnam S; Van Court B; Raben D; Young C; Heasley L; Karam SD
Mol Cancer Ther; 2018 Sep; 17(9):2049-2059. PubMed ID: 29970482
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases.
Miao H; Strebhardt K; Pasquale EB; Shen TL; Guan JL; Wang B
J Biol Chem; 2005 Jan; 280(2):923-32. PubMed ID: 15536074
[TBL] [Abstract][Full Text] [Related]
10. The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.
Jeon SH; Yoo JK; Kim CM; Lim ES; Lee SJ; Lee JM; Oh SH; Kim JK
Cell Death Dis; 2018 May; 9(5):493. PubMed ID: 29712908
[TBL] [Abstract][Full Text] [Related]
11. RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway.
Wang F; Yamauchi M; Muramatsu M; Osawa T; Tsuchida R; Shibuya M
J Biol Chem; 2011 Mar; 286(11):9097-106. PubMed ID: 21212275
[TBL] [Abstract][Full Text] [Related]
12. Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.
Wang AL; Li Y; Zhao Q; Fan LQ
Mol Med Rep; 2018 Jun; 17(6):7721-7729. PubMed ID: 29620230
[TBL] [Abstract][Full Text] [Related]
13. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
[TBL] [Abstract][Full Text] [Related]
14. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
15. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer.
Geng J; Li X; Zhou Z; Wu CL; Dai M; Bai X
Cancer Lett; 2015 Apr; 359(2):275-87. PubMed ID: 25633838
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase.
Kiely PA; Baillie GS; Barrett R; Buckley DA; Adams DR; Houslay MD; O'Connor R
J Biol Chem; 2009 Jul; 284(30):20263-74. PubMed ID: 19423701
[TBL] [Abstract][Full Text] [Related]
18. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC.
Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S
Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019
[TBL] [Abstract][Full Text] [Related]
19. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
